Hee Chul Yang, M.D., Ph.D., Jin Ho Choi, M.D., Moon Soo Kim, M.D., Jong Mog Lee, M.D.. Korean J Thorac Cardiovasc Surg 2020;53:226-32. https://doi.org/10.5090/kjtcs.2020.53.4.226
Background Prediction models for mediastinal metastasis and its detection by endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) have not been developed using a prospective cohort of potentially operable non-small cell lung cancer (NSCLC) patients. Research Question Can mediastinal metastasis and its detection by EBUS-TBNA be predicted with prediction models in NSCLC? Study Design and Methods For the prospective development cohort, 589 potentially operable NSCLC patients were evaluated (July 2016-June 2019) from 5 Korean teaching hospitals. Mediastinal staging was performed using EBUS-TBNA (± trans-esophageal approach). Surgery was performed for patients without cN2-3 disease by endoscopic staging. The Prediction model for Lung cancer Staging-Mediastinal metastasis (PLUS-M) and a model for mediastinal metastasis detection by EBUS-TBNA (PLUS-E) were developed using multivariable logistic regression analyses. Validation was performed using a retrospective cohort (n=309) from a different time period (June 2019-August 2021). Results The prevalence of mediastinal metastasis diagnosed by EBUS-TBNA plus surgery and the sensitivity of EBUS-TBNA in the development cohort were 35.3% and 87.0%, respectively. In PLUS-M, younger age ( 3-5 cm) and cN1 or cN2-3 stage by CT or PET-CT were significant risk factors for N2-3 disease. Areas under the receiver operating characteristic curves (AUCs) for PLUS-M and PLUS-E were 0.876 (95% CI, 0.845–0.906) and 0.889 (95% CI, 0.859–0.918), respectively. Model fit was good (PLUS-M: Homer-Lemeshow P=0.658, Brier score=0.129; PLUS-E: Homer-Lemeshow P=0.569, Brier score=0.118). In the validation cohort, PLUS-M (AUC, 0.859 [95% CI, 0.817-0.902], Homer-Lemeshow P=0.609, Brier score=0.144) and PLUS-E (AUC, 0.900 [95% CI, 0.865-0.936], Homer-Lemeshow P=0.361, Brier score=0.112) showed good discrimination ability and calibration. Interpretation PLUS-M and PLUS-E can be effectively used for decision making for invasive mediastinal staging in NSCLC.